Imaxe de Portada

Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases

The Special Issue of Biomedicines, entitled “Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases,” presents cutting-edge research findings, innovations, and insights into a wide range of topics related to the hepatobiliary system, such as the molecular mechanisms underlying disease p...

Descrición completa

Gardado en:
Formato: Online
Idioma:inglés
Publicado: MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
PBC
autoantibodies
glycoprotein gp210
nucleoporin p62
KLHL12 peptide
hepatitis B virus
hepatitis B X open reading frame
HBX 3′ end region
insertions
deletions
quasispecies
next-generation sequencing
cholestatic diseases
gene therapy
AAV
PFIC
RUNX1
NAFLD
NASH
metabolism
systems biology
ursodeoxycholic acid (UDCA)
obeticholic acid (OCA)
fibrates
FXR agonists
PPAR agonists
budesonide
transarterial chemoembolization
radiofrequency ablation
hepatocellular carcinoma
type 2 diabetes mellitus
non-alcoholic fatty liver disease
transient hepatic elastography
hepatic steatosis
liver fibrosis
primary biliary cholangitis
obeticholic acid
ursodeoxycholic acid
farnesoid X receptor
HCV
DAA
mitochondria
genotoxicity
side effect
chronic hepatitis B
nucleos(t)ide analogs
miR-125b
biomarker
fibrosis score
fatty liver
cirrhosis
females
gender
liver
n/a
thema EDItEUR::M Medicine and Nursing
Acceso en liña:ONIX_20230623_9783036577395_118
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
Summary:The Special Issue of Biomedicines, entitled “Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases,” presents cutting-edge research findings, innovations, and insights into a wide range of topics related to the hepatobiliary system, such as the molecular mechanisms underlying disease pathogenesis, diagnostic advancements, novel therapeutic approaches, and prevention strategies. The Special Issue comprises seven original articles and four review articles regarding NAFLD, primary biliary cholangitis (PBC), hepatitis B and C, and hepatocellular carcinoma (HCC).

Títulos similares